Cargando…

Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

Anti-VEGF antibody therapy with bevacizumab provides significant clinical benefit in patients with recurrent glioblastoma multiforme (GBM). Unfortunately, progression on bevacizumab therapy is often associated with a diffuse disease recurrence pattern, which limits subsequent therapeutic options. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huveldt, Deborah, Lewis-Tuffin, Laura J., Carlson, Brett L., Schroeder, Mark A., Rodriguez, Fausto, Giannini, Caterina, Galanis, Evanthia, Sarkaria, Jann N., Anastasiadis, Panos Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572988/ https://www.ncbi.nlm.nih.gov/pubmed/23457577 http://dx.doi.org/10.1371/journal.pone.0056505

Ejemplares similares

Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype
por: Lewis-Tuffin, Laura J., et al.
Publicado: (2010)

A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma
por: Lin, Wan-Hsin, et al.
Publicado: (2023)

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells
por: Allen, Cory, et al.
Publicado: (2012)

Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer
por: Kourtidis, Antonis, et al.
Publicado: (2015)

Brain metastases-derived extracellular vesicles induce binding and aggregation of low-density lipoprotein
por: Busatto, Sara, et al.
Publicado: (2020)

VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx
por: Ngok, Siu P., et al.
Publicado: (2012)

Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas
por: Higgins, Dominique M. O., et al.
Publicado: (2020)

The role of Src family kinases in growth and migration of glioma stem cells
por: HAN, XIAOSI, et al.
Publicado: (2014)

PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities
por: Sim, Hao-Wen, et al.
Publicado: (2022)

Specific Inhibition of SRC Kinase Impairs Malignant Glioma Growth In Vitro and In Vivo
por: Stedt, Hanna, et al.
Publicado: (2012)

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)
por: Galanis, Evanthia, et al.
Publicado: (2022)

Protein kinase C(ι) and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities
por: Kenchappa, Rajappa S., et al.
Publicado: (2021)

Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs
por: Zhang, Liang, et al.
Publicado: (2015)

Aurora-A Kinase as a Promising Therapeutic Target in Cancer
por: D’Assoro, Antonino B., et al.
Publicado: (2016)

Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial
por: Cohen, Adam L., et al.
Publicado: (2020)

The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma
por: Javier, Rodrigo, et al.
Publicado: (2022)

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
por: Jalalirad, Mohammad, et al.
Publicado: (2021)

The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling
por: Ichikawa-Tomikawa, Naoki, et al.
Publicado: (2023)

Regulation of the Src Family Kinases by Csk
por: Okada, Masato
Publicado: (2012)

Nuclear Functions of the Tyrosine Kinase Src
por: Bagnato, Giulia, et al.
Publicado: (2020)

HGG-10. Efficacy of convection-enhanced delivery of GB-13 (IL13.E13K-PE4E) in an orthotopic xenograft model of high-grade glioma is predicated on IL-13Rα2 expression.
por: Rechberger, Julian, et al.
Publicado: (2022)

Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues
por: Zhou, Dan, et al.
Publicado: (2018)

The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In Vivo
por: Eom, Keun-Yong, et al.
Publicado: (2016)

Protein tyrosine kinase 6 regulates activation of SRC kinase
por: Alwanian, Wanian M., et al.
Publicado: (2022)

TRANSLATIONAL RESEARCH-03 MULTIPLE MECHANISMS MODULATE TEMOZOLOMIDE RESISTANCE AND ARE POTENTIAL TARGETS FOR GLIOBLASTOMA THERAPY.
por: Kitange, Gaspar, et al.
Publicado: (2023)

N1-Src Kinase Is Required for Primary Neurogenesis in Xenopus tropicalis
por: Lewis, Philip A., et al.
Publicado: (2017)

Src kinase inhibition promotes the chondrocyte phenotype
por: Bursell, Laura, et al.
Publicado: (2007)

Regulation of Src Family Kinases in Human Cancers
por: Sen, Banibrata, et al.
Publicado: (2011)

The Role of Src Family Kinases in Prostate Cancer
por: Tatarov, Oleg, et al.
Publicado: (2007)

Phosphorylation of unique domains of Src family kinases
por: Amata, Irene, et al.
Publicado: (2014)

Src Kinase Regulation in Progressively Invasive Cancer
por: Xu, Weichen, et al.
Publicado: (2012)

Auto-thiophosphorylation activity of Src tyrosine kinase
por: Cabail, M. Zulema, et al.
Publicado: (2016)

The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes
por: De Kock, Lore, et al.
Publicado: (2020)

Dasatinib targets c-Src kinase in cardiotoxicity
por: Elmadani, Manar, et al.
Publicado: (2023)

C-terminal Src kinase (Csk) regulates the tricellular junction protein Gliotactin independent of Src
por: Samarasekera, G. D. N. Gayathri, et al.
Publicado: (2018)

TIPS-09 FIRST-IN-HUMAN PHASE 1 TRIAL OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTI-TUMOR ACTIVITY OF WSD0922-FU (NCT04197934): TRIAL IN PROGRESS
por: Kizilbash, Sani, et al.
Publicado: (2023)

LOCL-07 LOCO-REGIONAL INFUSION OF GB-13 (IL13.E13K-PE4E) AS A POTENTIALLY PROMISING TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA
por: Rechberger, Julian, et al.
Publicado: (2022)

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
por: Cha, Yongjun, et al.
Publicado: (2017)

p120 catenin is essential for mesenchymal cadherin–mediated regulation of cell motility and invasiveness
por: Yanagisawa, Masahiro, et al.
Publicado: (2006)

Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts
por: Higgins, Dominique M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_okfilbkv2k4ucu20rtt4nbl2uo